Calcium Levels Quickly Become Critical for Many Denosumab-Treated Women on Dialysis
(MedPage Today) -- Many women on dialysis quickly developed severe hypocalcemia after starting denosumab (Prolia) for osteoporosis, Medicare data showed.
During the first 12 weeks of treatment, 41.1% of women on denosumab developed severe hypocalcemia...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Calcium | Dialysis | Endocrinology | Medicare | Orthopaedics | Osteoporosis | Women | Xgeva